With more than $12 million in new funding from the National Institutes of Health, the Abramson Cancer Center at the University of Pennsylvania will build on its preclinical research of an emerging form of radiation that provides ultra-fast doses-;of under a second, compared to several minutes with conventional radiation-;and shows promise of greater protection of normal tissue, thereby minimizing toxic effects to the body.
Penn Medicine receives $12.3 million NIH grant to study FLASH radiotherapy for cancer
With more than $12 million in new funding from the National Institutes of Health, the Abramson Cancer Center at the University of Pennsylvania will build on its preclinical research of an emerging form of radiation that provides ultra-fast doses-;of under a second, compared to several minutes with conventional radiation-;and shows promise of greater protection of normal tissue, thereby minimizing toxic effects to the body.